M. Campbell

Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitor.

R. D. Connell, L. Pustilnik, Joel Morris, 2007, Cancer research.

Biochemical and pharmacological characterization of human c-Met neutralizing monoclonal antibody CE-355621

G. Karam, J. Lapointe, J. Xu, 2012, mAbs.

Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor.

Z. Hendsch, B. Posner, D. Kung, 2012, Bioorganic & medicinal chemistry letters.

The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer.

L. Pustilnik, S. Bhattacharya, J. Chen, 2007, Bioorganic & medicinal chemistry letters.

Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor.

Z. Hendsch, B. Posner, D. Kung, 2012, Bioorganic & medicinal chemistry letters.